Zoledronic acid is the drug used to treat Osteoporosis and other bone disorders especially for women. It is having several side effects like Osteonecrosis of the jaw.
Recently, European union advisory board has recommended measures to minimize osteonecrosis of the jaw. Pharmacovigilance Risk assessment committee(PRAC) of Europe has advised that the patients has to remind about adverse effects of Zoledronic acid and patients has to provide leaflets about side effects of drug.
PRAC also advised that patients has to provide leaflets which contain advantages of treatment with Zoledronic acid and disadvantages of treatment as osteonecrosis of jaw. It is very common side effect in menopause woman than men.
Recently, European union advisory board has recommended measures to minimize osteonecrosis of the jaw. Pharmacovigilance Risk assessment committee(PRAC) of Europe has advised that the patients has to remind about adverse effects of Zoledronic acid and patients has to provide leaflets about side effects of drug.
PRAC also advised that patients has to provide leaflets which contain advantages of treatment with Zoledronic acid and disadvantages of treatment as osteonecrosis of jaw. It is very common side effect in menopause woman than men.
.jpg) |
| Osteonecrosis of Jaw |
.jpg)
.jpg)
0 comments:
Post a Comment